The Evidence-to-Payment Gap: Why ENT Practices Need More Than Revenue Cycle Automation

An ENT surgeon evaluates a patient, establishes a diagnosis, recommends an appropriate procedure, and documents the medical necessity for treatment.

The patient may have spent months navigating referrals, diagnostic testing, medical therapy, and insurance requirements before reaching that decision.

Yet when the practice submits a prior authorization request or seeks payment, much of the information supporting that clinical decision may need to be reconstructed from disconnected records.

A denial may follow. Treatment is delayed. Administrative staff begin another round of document collection, appeals, and correspondence. In some cases, the procedure is ultimately performed, only for the payment to be challenged months or years later.

The problem is not necessarily that the clinical evidence was absent.

The problem is that healthcare has never developed a reliable infrastructure for connecting clinical evidence to the financial processes that determine whether physicians can sustainably deliver care.

This distinction matters because most current applications of artificial intelligence in revenue cycle management focus on accelerating existing administrative workflows.

AI can generate an appeal letter, suggest a billing code, identify a documentation deficiency, or classify a denial.

These are valuable capabilities. But they leave a more consequential question unanswered:

What if we designed AI to preserve, organize, and connect the evidence of appropriate care from the beginning of the patient journey through final payment?

For ENT surgeons, that could fundamentally change the economics of practice. For medical device executives, it could change how they think about market access, reimbursement support, and the infrastructure required for their technologies to reach appropriate patients.

Reimbursement Begins Long Before a Claim Is Submitted

Traditional revenue cycle management treats reimbursement as a sequence of financial transactions occurring primarily after a clinical service.

A patient receives care. A claim is generated. The payer adjudicates the claim. The practice evaluates payment and addresses exceptions.

But the evidence determining whether that care is authorized and reimbursed frequently originates much earlier.

Consider a patient undergoing evaluation for chronic rhinosinusitis.

Relevant information may include previous medical therapy, symptom history, examination findings, diagnostic imaging, treatment response, and the physician's clinical assessment.

Those details may have been recorded across multiple encounters, external referrals, imaging facilities, patient communications, and the EHR.

The information is clinically meaningful before the procedure is even considered. It may also become important during prior authorization or a subsequent medical necessity review.

Yet the practice often lacks a systematic method for preserving that information in a form that remains useful throughout the patient journey.

Instead, staff repeatedly collect and reassemble the same records whenever an insurer requests them.

This creates a costly separation between clinical care and reimbursement.

The evidence needed to support payment should be a product of accurately documented care, not a separate administrative project reconstructed after the fact.

An intelligent infrastructure layer could help close that gap by preserving relevant clinical information, recording its source and date, identifying missing elements, and making the evidence available when needed.

The objective would not be to manufacture medical necessity or modify documentation to satisfy an insurer.

It would be to ensure that information accurately supporting the physician's clinical judgment remains available and usable throughout the process.

The Real Reimbursement Problem Is Information Asymmetry

Insurance companies and physicians approach reimbursement from fundamentally different operational positions.

Large payers have access to extensive claims databases, reimbursement policies, contract information, utilization histories, and increasingly sophisticated analytical technologies.

Individual ENT practices often have limited visibility beyond their own billing systems, contracts, and payment histories.

The practice may know how much it billed and collected without having an efficient way to determine whether an individual payment was correct, whether a denial represents a recurring pattern, or whether its contractual reimbursement remains economically sustainable.

That asymmetry affects much more than administrative efficiency.

It influences negotiating leverage, the ability to challenge incorrect payments, and the practice's understanding of its financial performance.

Artificial intelligence creates an opportunity to reduce this imbalance, but only if physicians use it for more than producing appeal letters faster.

Consider three distinct reimbursement questions.

First, was the service appropriately supported and authorized?

Answering this requires relevant clinical evidence, accurate documentation, applicable coverage criteria, and an understanding of what information was available when the decision was made.

Second, was the service paid correctly?

This requires connecting the service performed, the submitted claim, the applicable contract, payer policies, remittance details, and subsequent adjustments.

Third, was the payment economically sustainable?

This requires understanding the actual cost of delivering the service, including staffing, equipment, supplies, physician time, overhead, and other relevant expenses.

These questions are related, but they are not interchangeable.

A claim can be correctly paid according to a contract that inadequately compensates the physician. A clinically appropriate procedure can be subject to a coverage dispute. A contractual underpayment can occur even when medical necessity was never questioned.

Traditional revenue cycle applications generally address portions of these problems.

AI infrastructure offers the potential to connect them.

From Documentation Automation to Longitudinal Evidence Intelligence

The next major opportunity in medical documentation may not be generating notes faster.

It may be making clinical information useful across multiple stages of care.

Imagine an ENT practice where an intelligent system maintains an organized, longitudinal record of the information relevant to an anticipated treatment pathway.

The patient has undergone previous medical management. Outside imaging becomes available. The physician documents clinical findings and determines whether an intervention is appropriate.

Rather than requiring staff to rediscover the same information during authorization, the infrastructure can identify which existing records are relevant, preserve their provenance, and flag information that is missing.

If the payer subsequently requests clarification, staff can retrieve the relevant documentation without reconstructing the entire clinical history.

If a payment dispute occurs months later, the practice can examine the evidence available at the time treatment was recommended, the policy applicable to the claim, and the decisions made during authorization.

This architecture requires more than a large language model reading a chart.

It requires accurate information extraction, reliable integration, versioned payer-policy knowledge, traceable evidence, and appropriate human review.

It also requires acknowledging that coverage policies, authorization criteria, and contractual terms can differ among payers and change over time.

The information used to support a decision must therefore be tied to the relevant date and applicable requirements.

The goal is not to guarantee reimbursement.

It is to improve the practice's ability to demonstrate what care was delivered, why it was clinically appropriate, and whether subsequent payment decisions were consistent with the applicable rules.

A Denied Procedure Is Also an Access Problem

Reimbursement is frequently described as a financial problem affecting the physician.

For patients awaiting treatment, its consequences can be more immediate.

A prior authorization denial can delay an appropriate intervention. Repeated administrative requests can prolong evaluation. Patients may abandon recommended care when navigating the process becomes too burdensome.

The American Medical Association's 2025 prior authorization survey found that 95% of surveyed physicians reported delays in necessary care associated with prior authorization, while 79% reported that authorization requirements at least sometimes lead patients to abandon recommended treatment.

These findings are based on physician reports across medical specialties, not ENT-specific patient outcomes. Nevertheless, they demonstrate why reimbursement processes cannot be considered independently from clinical access.

The implications for procedural specialties are particularly important.

When appropriate treatment does not occur because of an administrative obstacle, the economic consequences can extend beyond the missed professional payment.

The facility may lose an operative case. The practice may lose revenue associated with care it could appropriately have delivered. A medical device manufacturer may lose utilization associated with a procedure that never occurred.

Of course, not every patient referred for evaluation should undergo surgery.

Clinical ineligibility, informed refusal, and appropriate nonsurgical management are legitimate outcomes.

The opportunity is to distinguish those outcomes from patients who never reach treatment because of avoidable administrative barriers.

Without that distinction, practices and manufacturers cannot accurately determine how much of their apparent demand translates into appropriate care.

The Next Opportunity Is to Connect Clinical Value With Financial Reality

For too long, ENT practices have managed patient access, clinical documentation, authorization, reimbursement, and contract performance as separate administrative problems.

In reality, they are connected elements of the same clinical and economic system.

Information generated during patient intake can help prepare an appropriate consultation. Evidence collected during clinical evaluation can support authorization. Documentation of care can assist payment verification. Reimbursement patterns can inform practice strategy and contracting decisions.

When these activities remain disconnected, physicians and staff repeatedly reconstruct information while losing visibility into the full economics of delivering care.

At Nemedic, this understanding informs our development of Blue and our longer-term work on AI infrastructure for procedural healthcare. Our focus begins with the problems surgeons experience: helping appropriate patients reach treatment, reducing the administrative work surrounding care, and creating a stronger foundation for practice-level intelligence.

The broader opportunity is to establish a more continuous connection between the clinical evidence supporting treatment and the financial processes determining whether that treatment can be delivered sustainably.

For surgeons, this could mean more informed reimbursement decisions, less repetitive administrative work, and better visibility into the economics of care.

For medical device executives, it offers a reason to look beyond procedure adoption and examine the infrastructure responsible for moving appropriate patients from clinical need to treatment.

And for both groups, it suggests that the most consequential applications of AI may emerge where clinical information and financial decision-making intersect.

The future of reimbursement should not be an escalating contest between payer AI and physician AI, each generating more documentation, denials, and appeals.

It should be a system in which the evidence supporting appropriate care is available when needed, payment decisions can be meaningfully evaluated, and physicians have the information necessary to deliver care sustainably.

The next evolution of healthcare AI will not simply help physicians fight reimbursement problems faster.

It should help them understand and address those problems before they become barriers to patient care.